Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$1M Sell
16,940
-4,677
-22% -$267K 0.01% 746
2014
Q4
$1.22M Buy
21,617
+2,489
+13% +$134K 0.01% 682
2014
Q3
$870K Sell
19,128
-573
-3% -$27.9K 0.01% 700
2014
Q2
$1.02M Buy
19,701
+8,188
+71% +$402K 0.01% 659
2014
Q1
$562K Sell
11,513
-2,780
-19% -$135K 0.01% 817
2013
Q4
$620K Buy
14,293
+332
+2% +$13.6K 0.01% 751
2013
Q3
$533K Sell
13,961
-353
-2% -$12.4K 0.01% 773
2013
Q2
$444K Buy
+14,314
New +$427K 0.01% 807

Other funds holding VTRS

Baird's VTRS Position: Q1 2015 in Review

Baird reduced its Viatris (VTRS) stake by 22% in Q1 2015, selling an estimated $267K and leaving 16,940 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #746.

Baird first reported a position in VTRS in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.22M in Q4 2014. 618 funds tracked by Wall St. Rank hold VTRS as of Q1 2015.

  • Baird held 16,940 shares of Viatris worth $1M as of Q1 2015.
  • Baird sold 4,677 Viatris shares in Q1 2015, an estimated $267K.
  • Viatris made up 0.01% of Baird's portfolio in Q1 2015, its #746 holding.
  • Baird first reported a position in Viatris in Q2 2013 and has held it in 8 quarters since.
  • Baird's Viatris position peaked at $1.22M in Q4 2014.
  • 618 funds tracked by Wall St. Rank held Viatris as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.